9 found
Sort by:
  1. Türkay Dereli, Yavuz Coşkun, Eugene Kolker, Öner Güner, Mehmet Ağırbaşlı & Vural Özdemir (2014). Big Data and Ethics Review for Health Systems Research in LMICs: Understanding Risk, Uncertainty and Ignorance—And Catching the Black Swans? American Journal of Bioethics 14 (2):48-50.
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  2. Edward S. Dove & Vural Özdemir (2014). Glocal Bioethics: When International IRB Collaboration Confronts Local Politics. American Journal of Bioethics 14 (5):20-23.
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  3. Vural Ozdemir, Yann Joly, Edward S. Dove, Aspasia Karalis, Denise Avard & Bartha M. Knoppers (2012). Are We Asking the Right Ethics Questions on Drug Shortages? Suggestions for a Global and Anticipatory Ethics Framework. American Journal of Bioethics 12 (1):13 - 15.
    The American Journal of Bioethics, Volume 12, Issue 1, Page 13-15, January 2012.
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  4. Bartha M. Knoppers, Yann Joly & Vural Ozdemir (2011). ACCE, Pharmacogenomics, and Stopping Clinical Trials: Time to Extend the CONSORT Statement? American Journal of Bioethics 11 (3):11-13.
    (2011). ACCE, Pharmacogenomics, and Stopping Clinical Trials: Time to Extend the CONSORT Statement? The American Journal of Bioethics: Vol. 11, No. 3, pp. 11-13.
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  5. Vural Ozdemir & Bartha Maria Knoppers (2010). One Size Does Not Fit All: Toward “Upstream Ethics”? American Journal of Bioethics 10 (6):42-44.
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  6. Vural Ozdemir (2009). What To Do When the Risk Environment Is Rapidly Shifting and Heterogeneous? Anticipatory Governance and Real-Time Assessment of Social Risks in Multiply Marginalized Populations Can Prevent IRB Mission Creep, Ethical Inflation or Underestimation of Risks. American Journal of Bioethics 9 (11):65-68.
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  7. Zubin Master & Vural Özdemir (2008). Selling Translational Research: Is Science a Value-Neutral Autonomous Enterprise? American Journal of Bioethics 8 (3):52-54.
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  8. Bryn Williams-Jones & Vural Ozdemir (2008). Challenges for Corporate Ethics in Marketing Genetic Tests. Journal of Business Ethics 77 (1):33 - 44.
    Public discussions of ethical issues related to the biotechnology industry tend to treat “biotechnology” as a single, undifferentiated technology. Similarly, the pros and cons associated with this entire sector tend to get lumped together, such that individuals and groups often situate themselves as either “pro-” or “anti-” biotechnology as a whole. But different biotechnologies and their particular application context pose very different challenges for ethical corporate decision-making. Even within a single product category, different specialty products can pose strikingly different ethical (...)
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation